Announcements Trials

Browse Landscape

Phase

Status

Recruiting 27 Active not recruiting 10 Not yet recruiting 9 Completed 8 Terminated 3 Withdrawn 1 Suspended 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Neoplasms 26 Prostatic Neoplasms 22 Colorectal Neoplasms 18 Head and Neck Neoplasms 14 Pancreatic Neoplasms 12 Melanoma 10 Lung Neoplasms 10 Brain Neoplasms 10 Neoplasm Metastasis 9 Carcinoma, Renal Cell 9 Squamous Cell Carcinoma of Head and Neck 8 Carcinoma, Non-Small-Cell Lung 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Lymphoma, Follicular 7 Lymphoma 7 Glioblastoma 7 Leukemia, Myeloid, Acute 6 Leukemia 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Lymphoma, B-Cell 5 Kidney Neoplasms 5 Hematologic Neoplasms 5 Sarcoma 4 Liver Neoplasms 4

Interventions

pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 aldesleukin 1 Interleukin-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Adenocarcinoma of Lung × 1 year × Clear all

NCT05566223 2026-02-23

CheckCell-2

Intima Bioscience, Inc.

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡